InvestorsHub Logo
Followers 7
Posts 351
Boards Moderated 0
Alias Born 11/13/2016

Re: None

Saturday, 11/05/2022 6:00:00 PM

Saturday, November 05, 2022 6:00:00 PM

Post# of 462883
" A December To Remember " ?

A guess as to a possible strategy in play:

TGD has the trial results in hand and they are very good. He also knows that the significant short interest ( some of which are quite possibly backed by various BP's that have a lot to lose if Anavex succeeds given the considerable number of indications Anavex could treat with its molecules ) will not go down without a substantial fight.

I believe TGD will maintain radio silence on the results until 12/1. By doing so, he accomplishes the following:

1. He keeps the shorts at bay with no results to attack with AF style distortion pieces.
With everyday that passes this month the odds of a notice of a failed trial diminish. The last ten days of the month should be interesting to witness, to see which shorts blink and start to cover.

2. The 12/1 release of the TLD shortens the time frame until release of the confirming
peer review study, which should help to counter the activities of the shorts.

3. By waiting 'til after 12/1 TLD to release the half dozen or so expected other news releases, it adds a huge multiplier effect to the impact on each new indication mentioned; adding greatly to the calculation of Anavex's future value.

4. A constant barrage of press releases in December following positive TLD should knock the shorts on their rear ends.

Again, just guessing here, but if you know you are going to be attacked, this might be an effective way to deal with it.

jmvho
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News